Arkolith/Insider Trading/NBY/Form 4

Poplar Point Capital Partners LP

10% OwnerNovaBay Pharmaceuticals, Inc. (NBY) · full profile →Form 4 · filed Apr 15, 2025
Net Buying
Open-Market Buys
$75K
Open-Market Sells
$0
Net Open-Market Flow
$75K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2025Buy(P)20K$0.59$12K992K
Mar 31, 2025Buy(P)22K$0.59$13K972K
Mar 28, 2025Buy(P)49K$0.61$30K950K
Mar 27, 2025Buy(P)600$0.61$366901K
Mar 27, 2025Buy(P)19K$0.62$11K900K
Mar 26, 2025Buy(P)13K$0.61$8K881K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001398344-25-007146) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML